Day: June 14, 2023

PITTSBURGH, June 14, 2023 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without triggering the immune system, today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, to be effective as of 5:00 p.m. Eastern Time today, June 14, 2023. The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Thursday, June 15, 2023. Following the reverse stock split, the Company’s common stock will continue to trade on The Nasdaq Capital Market under the symbol “NBSE” with the new CUSIP number, 64132K201. The reverse stock split is intended for the Company to regain compliance with...

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain, announces that at its Annual General Meeting and subsequent General Meeting held earlier today, all resolutions put to the Company’s shareholders were duly passed. The full text of, inter alia, the resolutions proposed and passed at the Annual General Meeting and General Meeting can be found in the Notices of the Annual General Meeting and General Meeting on the Company’s website at:https://biodexapharma.com/investors/corporate-governance//#company-informationFor more information, please contact:Biodexa Pharmaceuticals...

Skkynet Announces Fiscal Quarter-end Results for Q2 2023 With Record Sales Growth of 16% MISSISSAUGA, ONTARIO, June 14, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Skkynet Cloud Systems, Inc. (“Skkynet” or “the Company”) (OTCQB: SKKY) is pleased to announce its quarter-end operating and financial results for the period ended April 30, 2023. The Company reported a record second quarter revenue of $625,464 compared to $540,093 for the same period in 2022, a 16% year over year revenue growth. Comprehensive loss from operations for the 3-month period was $90,740 compared to $19,475 for the same period in 2022 due to increased headcount for expanding operations and capabilities, including development of new DataHub version 11, due for beta release in Q3.  Development of applications to leverage AI within the DataHub product stack is...

Pure-Vu system featured in live case during an underwater large polyp resection in the colon Over 1,000 physicians registered for IECED Live Endoscopy Course from across Latin America Pure-Vu Gen 4 Gastro and Colon on track for FDA submission in Q4 2023FORT LAUDERDALE, Fla., June 14, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, today announced that the Pure-Vu Gen 4 Gastro and Colon system was featured during the 9th Ecuadorian Institute of Digestive Diseases (IECED) Live Endoscopy Course 2023 at the Pentax Learning Center, which is considered one of the most important digestive medicine annual events held in the Latin American region with over 1,000 physicians registered. During a live case...

XIAMEN, China, June 14, 2023 (GLOBE NEWSWIRE) — Hitek Global Inc. (Nasdaq: HKIT) (the “Company“), a China-based information technology consulting and solutions service provider, announced today that it received a government reward (the “Reward”) of RMB 1 million for its successful listing to the Nasdaq Capital Market on March 31, 2023. This significant recognition highlights the Company’s contribution to the local business community. The Reward, bestowed by the local government, underscores the positive impact the Company has had on the community. By going public, the Company has not only achieved a significant milestone in its corporate journey but has also demonstrated its adherence to transparency, accountability, and corporate governance standards. Ms. Xiaoyang Huang, Chief Executive Officer and Director of...

ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest. Healthcare Virtual Conference Presented by Maxim:Date: Wednesday, June 21, 2023Time: 2:00 PM ETEvent: Company DiscussionVirtual viewers: register to join M-Vest here For more information regarding the conference and to register to watch the presentation live, please visit the conference page here. About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the...

SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will present at the Healthcare Virtual Conference presented by Maxim Group LLC and hosted by M-Vest, being held June 20 – 22, 2023. Ms. Johnson’s presentation is scheduled for Tuesday, June 20th at 3:00 p.m. EDT. A live webcast of the presentation will be available at https://m-vest.com/events/healthcare-06202023 and under “Presentations, Events & Webcasts” in the Investors section of the company’s website at https://ir.darebioscience.com. The webcast will be archived in the same section of the Company’s website and available for replay until July 5, 2023. About Daré Bioscience Daré Bioscience is a biopharmaceutical...

SANTA MONICA, Calif., June 14, 2023 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLGG), a global leader in providing immersive experiences across the world’s largest metaverse gaming platforms, takes another leap into the gaming metaverse, this time with Clarks, the legendary innovative shoemaker, with the launch of the exhilarating PLAYPRINTS World on Roblox. This exciting partnership began with Melon, acquired in May 2023 by Super League. Together with Clarks, the two companies have created a suite of immersive influencer activities alongside an engaging YouTube channel spotlighting the thrilling adventures of the PLAYPRINTS squad. Guided by super-powered PLAYPRINTS sneakers and PLAYPRINTS heroes, players are tasked with exploring fantastical worlds as they navigate this immersive digital experience. They can also explore Clarks’...

YAVNE, Israel, June 14, 2023 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced its participation in the upcoming Healthcare Virtual Conference Part II, organized by Maxim Group LLC and hosted by M-Vest. The conference will take place online from June 20 to June 22, 2023. Ofer Gonen, Chief Executive Officer of MediWound, will participate in a fireside chat with Michael Okunewitch, Senior Research Analyst at Maxim Group on June 20 at 9:30am ET. This conference will be live on M-Vest. To attend, sign up to become an M-Vest member and register here. About MediWound Ltd.MediWound Ltd. (Nasdaq: MDWD) is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Specializing...